Edgard Julien Sonkwa Lontsi

Brentuximab Vedotin and Bendamustine Protocol in Hodgkin Lymphoma: Report of Two Cases in Abidjan, Côte d'Ivoire

Boidy Kouakou, Edgard Julien Sonkwa Lontsi, Yao Nicaise Atiméré, Alexis Dohoma Silué, Ismael Kamara, Danho Clotaire Nanho, Ruth Djeket, Emeraude Ndathz-Comoé, Daouda Koné, Norman Isaac Klebair Kouamé, Emmanuela Hiabba Assohou-Koffi & Gustave Kouassi Koffi · International Blood Research & Reviews · 2025

Background: Hodgkin lymphoma is the first hematology malignancy to be cured. The Management of mediastinal or pulmonary location, whether inaugural or secondary, is restricted with conventional chemotherapy which contains cardio- or pneumotoxic molecules. The new Advanced therape...

Open access Research Article 10.9734/ibrr/2025/v16i4372

Progression of Albuminuria in Sickle Cell Disease at the Clinical Hematology Department in Abidjan

Boidy Kouakou, Edgard Julien Sonkwa Lontsi, Alexis Dodoma Silué, Yao Nicaise Atiméré, Ismael Kamara, Danho Clotaire Nanho, Ruth Djeket, Emeraude Ndathz-Comoé, Daouda Koné, Norman Isaac Klebair Kouamé, Emmanuela Hiabba Assohou-Koffi & Gustave Kouassi Koffi · International Blood Research & Reviews · 2025

Introduction: Sickle cell disease (SCD) is the most common hemoglobinopathy worldwide. It is of significant public health importance in Sub-Saharan Africa. The SCD nephropathy is a major contributor to the morbidity and mortality. The Early detection and prevention of Albuminuria...

Open access Research Article 10.9734/ibrr/2025/v16i4370